-
The goals of this study were fourfold: 1) to increase implementation rates of evidence-based interventions that have been shown to reduce ICU mortality and morbidity; 2) to design tools to promote team communication and team building; 3) to develop prompts that could be incorporated into an ICU progress note to promote consistent use of these measures; and 4) to provide "real time"' feedback regarding progress.
-
In this issue: Individualization of therapy with pharmacogenetics; the rate vs rhythm debate; the FDA's Risk Evaluation and Mitigation Strategy; FDA actions.
-
Use of the benzodiazepine-like hypnotics (z-hypnotics), zolpidem and zopiclone, is associated with an increased risk of crash, particularly in young people.
-
-
Hypovitaminosis D was found to be highly prevalent in U.S. adults with CVD, particularly those with both coronary heart disease and heart failure.
-
Vitamin B12 was effective in the treatment of recurrent aphthous stomatitis.
-
The FDA has approved another selective serotonin and norepinephrine reuptake inhibitor for the management of fibromyalgia (FM).
-
Actinic keratoses (AK) areat bestprecancerous skin lesions, and at worst (a belief held by many leaders in the skin cancer field), skin carcinoma in situ.
-
The emergency department assessment of appendicitis has sure changed a lot in the past 30 years.
-
